Skip to main content
. Author manuscript; available in PMC: 2010 Aug 23.
Published in final edited form as: Ther Drug Monit. 2009 Aug;31(4):443–450. doi: 10.1097/FTD.0b013e3181a8f0ae

Figure 3.

Figure 3

Examples of concentration-time profiles of MPA measured using the enzymatic MPA assay and estimated using the Bayesian method and the 20 min-1h–3h sampling schedule. A) Profile obtained early after transplantation in a patient given tacrolimus, showing a double plasma concentration peak. B) Profile obtained in a stable patient given cyclosporine, with no second concentration peak.